동물 태반 단백질 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제품 유형별, 용도별, 동물원별, 유통 채널별, 지역별 및 경쟁(2021-2031년)
Animal Placental Protein Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Application, By Animal Source, By Distribution Channel, By Region & Competition, 2021-2031F
상품코드:1934226
리서치사:TechSci Research
발행일:2026년 01월
페이지 정보:영문 180 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 동물 태반 단백질 시장은 2025년 5억 4,462만 달러에서 2031년까지 7억 4,075만 달러로 확대하며, CAGR 5.26%를 기록할 것으로 예측되고 있습니다.
이 생리활성 성분은 돼지, 양, 말 등 포유류의 분만 후 조직에서 추출한 것으로 효소, 아미노산, 성장인자를 풍부하게 함유하고 있다는 점에서 높은 평가를 받고 있습니다. 시장 성장은 주로 강력한 노화 방지 성분을 필요로 하는 급성장하는 화장품 산업과 조직 회복을 위한 재생의료의 적용 확대에 의해 주도되고 있습니다. 또한 영양이 풍부한 장기에서 추출한 영양 보충제에 대한 소비자의 관심이 높아지면서 이러한 특수 단백질 분획에 대한 상업적 수요가 증가하고 있습니다.
시장 개요
예측 기간
2027-2031
시장 규모 : 2025년
5억 4,462만 달러
시장 규모 : 2031년
7억 4,075만 달러
CAGR : 2026-2031년
5.26%
가장 빠르게 성장하는 부문
캡슐/정제
최대 시장
북미
그러나 이 분야는 질병 전파를 방지하고 동물성 제품별 생물학적 안전성을 보장하기 위한 엄격한 규제로 인해 심각한 장벽에 직면해 있습니다. 중국축산협회의 자료에 따르면 2024년에는 시장공급과잉을 관리하기 위해 업계는 전략적으로 번식용 모돈 수를 약 100만 마리 정도 줄였다고 합니다. 이러한 움직임은 돼지 태반 단백질 원료의 가용성을 직접적으로 제한하는 것입니다. 이러한 가축 사육두수의 변동은 안정적인 생산량을 유지하기 위해 돼지 유래 원료에 의존하고 있는 제조업체들에게 큰 도전이 되고 있습니다.
시장 성장 촉진요인
세계 동물 태반 단백질 시장의 주요 촉진요인은 피부 회춘 및 노화 방지 화장품에 대한 수요 증가입니다. 소비자들이 비침습적 미용 개선에 대한 선호도가 높아짐에 따라 콜라겐 합성을 촉진하고 시술 후 회복을 가속화하는 생물학적 활성 성분의 사용이 급증하고 있습니다. 이러한 추세는 국제미용성형외과학회(ISAPS)의 2024년 6월 자료에 따르면 전년도 전 세계 비수술적 시술 건수가 1,910만 건으로 보고되어 태반 성분을 함유한 애프터케어 제품에 대한 강력한 시장 기반이 구축되어 있습니다. 제조업체들은 이에 대응하여 임상 치료의 재생 효과를 재현하는 화장품에 단백질 분획을 배합하고 있으며, 이것이 원료 추출물의 대량 조달을 견인하고 있습니다.
동시에 상처 치료 및 재생의료 분야에서의 응용 확대도 시장을 촉진하고 있습니다. 이러한 분야에서 동물 유래 스캐폴드는 조직공학에서 매우 중요한 역할을 합니다. 최근 임상연구를 통해 복잡한 피부 손상에 대한 이들 바이오 매트릭스의 효능이 확인되면서 의료현장에서의 수용이 진행되고 있습니다. 예를 들어 2024년 12월 Cureus 저널에 발표된 실제 임상 연구에 따르면 돼지 태반 유래 세포외 기질이 난치성 상처의 53%에서 완전 폐쇄를 촉진하는 것으로 나타나 그 치료적 가치를 입증했습니다. 이러한 의료용 용도를 지속하기 위해 공급망은 견고하게 유지되고 있습니다. 뉴질랜드 사슴산업국의 보고에 따르면 생물 활성 성분 추출의 중요한 원료인 사슴 제품별 수출량은 2024년 9월까지 4,944톤에 달하고, 치료 분야에 필요한 고품질 원료의 안정적 공급이 확보되어 있다고 합니다.
시장이 해결해야 할 과제
시장 성장의 주요 장벽은 세계 가축 재고 변동으로 인한 원료 공급망의 불균일성입니다. 동물 태반 단백질 생산은 산후 조직 수집에 전적으로 의존하므로 말, 양, 돼지 떼의 규모 축소에 매우 민감합니다. 경제적 요인, 질병 발생, 규제에 따른 개체군 관리로 인해 번식 개체수가 감소하면 추출 가능한 생물학적 물질의 양이 감소합니다. 이러한 의존성은 심각한 생산 병목현상을 야기하고, 제조업체가 증가하는 상업적 수요를 충족하는 데 필요한 재고 수준을 유지하는 데 어려움을 겪고 있습니다.
미국 양산업협회에 따르면 2024년 미국의 양과 양고기 사육두수는 2% 감소할 것으로 예상되며, 이는 양에서 추출한 원료공급원이 지속적으로 줄어들고 있음을 보여줍니다. 이러한 생물학적 기반의 감소는 양 유래 원료공급 능력을 직접적으로 제한합니다. 그 결과, 제조업체들은 희소한 자원을 둘러싼 경쟁 심화와 조달 비용 상승에 대응해야 하며, 이는 사업 확장에 걸림돌이 되어 태반 단백질 부문 전체의 성장을 둔화시키고 있습니다.
시장 동향
국내 화장품에서 돼지 태반 단백질의 사용이 눈에 띄게 증가하면서 시장 구조가 재편되고 있습니다. 이 원료가 인간의 피부와 높은 조직 적합성을 보인다는 점, 그리고 K-Beauty 브랜드의 세계 진출이 그 배경입니다. 제조업체들이 앰플과 시트 마스크를 개선하고 이 생물학적 친화력을 활용함에 따라 완제품 수출이 급증했습니다. 국제적인 수요를 충족시키기 위해 돼지 원료의 대량 조달이 필요하게 되었습니다. 이러한 추세는 2025년 1월 한국 관세청 무역 데이터에 의해 지원되고 있으며, 2024년 미국으로의 스킨케어 제품 수출액이 8억 1,510만 달러로 3배 이상 증가한 것으로 나타났습니다. 이는 이러한 태반 강화 제품이 유럽과 미국 시장에 유입되는 거대한 상업적 경로를 강조하고 있습니다.
동시에 중동과 동남아시아의 엄격한 규제 시장을 겨냥한 할랄 인증 양태반 추출물이 빠르게 부상하고 있습니다. 종교적 적합성을 보장하기 위해 생산자들은 돼지 유래 성분을 양 유래 대체품으로 대체하는 움직임을 가속화하고 있으며, 호주와 같은 주요 수출국에서의 기록적인 생물학적 이용 가능성은 이러한 전략을 지원하고 있습니다. 이러한 공급 능력은 할랄 요건을 충족하는 데 필수적입니다. 호주 육류 축산국(MLA)의 2024년 9월 '양 산업 예측' 보고서에 따르면 국내 양 사육두수는 2024년 6월에 7,910만 마리로 2007년 이후 최고치를 기록하여 이러한 특수 제제에 추적 가능하고 안정적인 원료 기반을 제공할 것으로 예측됩니다.
The Global Animal Placental Protein Market is projected to expand from USD 544.62 Million in 2025 to USD 740.75 Million by 2031, registering a CAGR of 5.26%. This bioactive ingredient, derived from the postpartum tissues of mammals like swine, sheep, and horses, is prized for its rich content of enzymes, amino acids, and growth factors. The market's growth is largely fueled by the booming cosmeceutical industry, which demands potent anti-aging ingredients, and the rising application of regenerative therapies for tissue repair. Furthermore, increasing consumer interest in nutrient-rich, organ-based dietary supplements is strengthening commercial demand for these specialized protein fractions.
Market Overview
Forecast Period
2027-2031
Market Size 2025
USD 544.62 Million
Market Size 2031
USD 740.75 Million
CAGR 2026-2031
5.26%
Fastest Growing Segment
Capsules/Tablets
Largest Market
North America
However, the sector encounters significant obstacles arising from strict regulations designed to prevent disease transmission and ensure the biological safety of animal by-products. Data from the China Animal Agriculture Association indicates that in 2024, the industry strategically reduced the breeding sow herd by roughly 1 million heads to manage market oversupply, a move that directly limits the availability of raw materials for porcine placental protein. This variability in livestock numbers poses a considerable challenge for manufacturers who depend on porcine sources to maintain stable production volumes.
Market Driver
A primary catalyst for the global animal placental protein market is the escalating demand for skin rejuvenation and anti-aging cosmetic products. With consumers increasingly favoring non-invasive aesthetic improvements, there is a corresponding surge in the use of bioactive ingredients that promote collagen synthesis and accelerate post-procedure recovery. This trend is supported by June 2024 data from the International Society of Aesthetic Plastic Surgery, which reported 19.1 million non-surgical procedures globally in the previous year, establishing a strong market for placenta-infused aftercare solutions. Manufacturers are responding by incorporating protein fractions into cosmeceuticals that replicate the regenerative benefits of clinical treatments, driving substantial procurement of raw extracts.
Simultaneously, the market is bolstered by growing applications in wound care therapeutics and regenerative medicine, where animal-derived scaffolds are crucial for tissue engineering. Recent clinical progress has confirmed the effectiveness of these biological matrices for complex skin injuries, enhancing their medical acceptance. For example, a real-world study published in Cureus in December 2024 showed that porcine placental extracellular matrix facilitated complete closure in 53% of hard-to-heal wounds, highlighting its therapeutic value. To sustain these medical-grade uses, the supply chain remains robust; Deer Industry New Zealand reported that exports of deer co-products, a vital source for bioactive extraction, reached 4,944 tonnes in the year ending September 2024, ensuring the high-quality raw material availability needed for the therapeutic sector.
Market Challenge
The main obstacle to market growth is the inconsistency of raw material supply chains caused by fluctuations in global livestock inventories. Because animal placental protein production depends entirely on collecting postpartum tissue, the industry is highly sensitive to any reductions in equine, ovine, or swine herd sizes. When breeding populations shrink due to economic factors, disease outbreaks, or regulatory herd management, the quantity of extractable biological material falls. This reliance creates major production bottlenecks, making it difficult for manufacturers to maintain the inventory levels necessary to satisfy increasing commercial demand.
According to the American Sheep Industry Association, the total inventory of sheep and lambs in the United States fell by 2 percent in 2024, indicating a persistent contraction in ovine sources. This decline in the biological foundation directly limits the supply capacity for ingredients derived from sheep. Consequently, manufacturers must contend with intensified competition for scarce resources and rising procurement costs, which hinders their ability to expand operations and slows the overall growth of the placental protein sector.
Market Trends
The market is being reshaped by a marked increase in the use of porcine-derived placental protein in Korean cosmetic formulations, driven by the ingredient's strong histocompatibility with human skin and the global reach of K-Beauty brands. As manufacturers update ampoules and sheet masks to leverage this biological affinity, exports of these finished products have surged, requiring greater volumes of porcine raw materials to fulfill international demand. This trend is confirmed by trade data from the Korea Customs Service in January 2025, which notes that skincare exports to the United States more than tripled to $815.1 million in 2024, highlighting the massive commercial channel through which these placenta-enriched products are entering Western markets.
Concurrently, there is a rapid emergence of Halal-certified ovine placenta extracts aimed at strictly regulated consumer markets in the Middle East and Southeast Asia. To ensure religious compliance, producers are increasingly replacing porcine ingredients with sheep-derived alternatives, a strategy supported by record biological availability from major exporters like Australia. This supply capacity is essential for meeting Halal requirements; according to Meat & Livestock Australia's September 2024 'Sheep Industry Projections' report, the national flock peaked at 79.1 million head in June 2024, the highest level since 2007, providing a traceable and stable raw material base for these specialized formulations.
Key Market Players
Merck KGaA
Biotain Pharma Co., Ltd.
New Zealand Health Food Company Limited
XABC Biotech Co., Ltd.
Chaitanya Biologicals Pvt. Ltd.
Serolab SA
Auckland BioSciences Limited
ANZCO Foods Limited
Biocontinental Co., Ltd.
Report Scope
In this report, the Global Animal Placental Protein Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Animal Placental Protein Market, By Product Type
Extracts
Powders
Capsules/Tablets
Injections
Animal Placental Protein Market, By Application
Pharmaceuticals
Cosmetics and Personal Care Products
Nutraceuticals and Dietary Supplements
Research
Biotechnology
Animal Placental Protein Market, By Animal Source
Bovine
Porcine
Ovine
Equine
Others
Animal Placental Protein Market, By Distribution Channel
Direct Sales
Retail Sales
Online Retail
Animal Placental Protein Market, By Region
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Animal Placental Protein Market.
Available Customizations:
Global Animal Placental Protein Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Animal Placental Protein Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Type (Extracts, Powders, Capsules/Tablets, Injections)
5.2.2. By Application (Pharmaceuticals, Cosmetics and Personal Care Products, Nutraceuticals and Dietary Supplements, Research, Biotechnology)
5.2.3. By Animal Source (Bovine, Porcine, Ovine, Equine, Others)
5.2.4. By Distribution Channel (Direct Sales, Retail Sales, Online Retail)
5.2.5. By Region
5.2.6. By Company (2025)
5.3. Market Map
6. North America Animal Placental Protein Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type
6.2.2. By Application
6.2.3. By Animal Source
6.2.4. By Distribution Channel
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Animal Placental Protein Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product Type
6.3.1.2.2. By Application
6.3.1.2.3. By Animal Source
6.3.1.2.4. By Distribution Channel
6.3.2. Canada Animal Placental Protein Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product Type
6.3.2.2.2. By Application
6.3.2.2.3. By Animal Source
6.3.2.2.4. By Distribution Channel
6.3.3. Mexico Animal Placental Protein Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product Type
6.3.3.2.2. By Application
6.3.3.2.3. By Animal Source
6.3.3.2.4. By Distribution Channel
7. Europe Animal Placental Protein Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Application
7.2.3. By Animal Source
7.2.4. By Distribution Channel
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Animal Placental Protein Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product Type
7.3.1.2.2. By Application
7.3.1.2.3. By Animal Source
7.3.1.2.4. By Distribution Channel
7.3.2. France Animal Placental Protein Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product Type
7.3.2.2.2. By Application
7.3.2.2.3. By Animal Source
7.3.2.2.4. By Distribution Channel
7.3.3. United Kingdom Animal Placental Protein Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product Type
7.3.3.2.2. By Application
7.3.3.2.3. By Animal Source
7.3.3.2.4. By Distribution Channel
7.3.4. Italy Animal Placental Protein Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product Type
7.3.4.2.2. By Application
7.3.4.2.3. By Animal Source
7.3.4.2.4. By Distribution Channel
7.3.5. Spain Animal Placental Protein Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product Type
7.3.5.2.2. By Application
7.3.5.2.3. By Animal Source
7.3.5.2.4. By Distribution Channel
8. Asia Pacific Animal Placental Protein Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Application
8.2.3. By Animal Source
8.2.4. By Distribution Channel
8.2.5. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Animal Placental Protein Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product Type
8.3.1.2.2. By Application
8.3.1.2.3. By Animal Source
8.3.1.2.4. By Distribution Channel
8.3.2. India Animal Placental Protein Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product Type
8.3.2.2.2. By Application
8.3.2.2.3. By Animal Source
8.3.2.2.4. By Distribution Channel
8.3.3. Japan Animal Placental Protein Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product Type
8.3.3.2.2. By Application
8.3.3.2.3. By Animal Source
8.3.3.2.4. By Distribution Channel
8.3.4. South Korea Animal Placental Protein Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product Type
8.3.4.2.2. By Application
8.3.4.2.3. By Animal Source
8.3.4.2.4. By Distribution Channel
8.3.5. Australia Animal Placental Protein Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product Type
8.3.5.2.2. By Application
8.3.5.2.3. By Animal Source
8.3.5.2.4. By Distribution Channel
9. Middle East & Africa Animal Placental Protein Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By Application
9.2.3. By Animal Source
9.2.4. By Distribution Channel
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Animal Placental Protein Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product Type
9.3.1.2.2. By Application
9.3.1.2.3. By Animal Source
9.3.1.2.4. By Distribution Channel
9.3.2. UAE Animal Placental Protein Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product Type
9.3.2.2.2. By Application
9.3.2.2.3. By Animal Source
9.3.2.2.4. By Distribution Channel
9.3.3. South Africa Animal Placental Protein Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product Type
9.3.3.2.2. By Application
9.3.3.2.3. By Animal Source
9.3.3.2.4. By Distribution Channel
10. South America Animal Placental Protein Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product Type
10.2.2. By Application
10.2.3. By Animal Source
10.2.4. By Distribution Channel
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Animal Placental Protein Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product Type
10.3.1.2.2. By Application
10.3.1.2.3. By Animal Source
10.3.1.2.4. By Distribution Channel
10.3.2. Colombia Animal Placental Protein Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product Type
10.3.2.2.2. By Application
10.3.2.2.3. By Animal Source
10.3.2.2.4. By Distribution Channel
10.3.3. Argentina Animal Placental Protein Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product Type
10.3.3.2.2. By Application
10.3.3.2.3. By Animal Source
10.3.3.2.4. By Distribution Channel
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Animal Placental Protein Market: SWOT Analysis
